SR9009 (Stenabolic)
Rev-erbα agonist (Stenabolic — NOT a SARM)
Also known as SR9009, stenabolic, sr-9009
Half-life
~1-2 hours
What is SR9009 (Stenabolic)?
REV-ERB agonist research chemical marketed for circadian and endurance effects.
How SR9009 (Stenabolic) works
Agonizes REV-ERB nuclear receptors affecting clock genes, mitochondrial biogenesis, and substrate utilization in preclinical models.
Benefits & uses
- Endurance/stamina (in animal models)
- Fat loss interest
- Non-hormonal
Common uses: Endurance, fat loss (marketed; poor oral bioavailability).
SR9009 (Stenabolic) dosage
Protokol doesn't recommend doses for prescription or controlled compounds. Any figures below are reference or observational reports — dosing should be set with a qualified clinician.
- Protocol notes
- 20-30mg daily split 3-4x due to very short half-life. Non-suppressive. Endurance and fat loss focused.
- Commonly reported
- Observational; note poor oral absorptionObservational use reports — not a recommendation.
SR9009 (Stenabolic) half-life
~1-2 hours
SR9009 (Stenabolic) side effects
- Insomnia if dosed late
- Injection/oral bioavailability issues
- Weak human evidence
- Non-suppressive
- Limited human data
- Effects may not translate orally (bioavailability)
Warnings & monitoring
- Poor oral bioavailability — real-world oral effect is questionable. Educational reference only
- Minimal human data
- Gray-market; not approved for human use
SR9009 (Stenabolic) interactions
with Cardarine
Compatible · lowSR9009 (Stenabolic) is a Rev-Erb agonist improving metabolic rate and endurance via circadian rhythm modulation; Cardarine activates PPARδ for fat oxidation. Complementary endurance/fat loss stack.
Timing: Both taken multiple times per day due to short half-lives (4–5h); pre-workout ideal
